Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jibo Han

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Theranostics|February 3, 2025
Deubiquitinase MYSM1 drives myocardial ischemia/reperfusion injury by stabilizing STAT1 in cardiomyocytesXiaowen Shi, Jianjiang Xu, Lei Liu, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2025
MYSM1 Mediates Cardiac Parthanatos and Hypertrophy by Deubiquitinating PARP1Xin Zhong, Jianjiang Xu, Xiaowen Shi, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
Schisandrin B attenuates lipopolysaccharide-induced activation of hepatic stellate cells through Nrf-2-activating anti-oxidative activityZhongcai Yao, Jibo Han, Shuyi Lou, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac RemodelingJibo Han, Shiju Ye, Chunpeng Zou, et al.
Basic Research in Cardiology|December 26, 2016
MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathwayJibo Han, Chunpeng Zou, Liqin Mei, et al.
Cell Communication and Signaling : CCS|December 19, 2024
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytesXiaowen Shi, Jianjiang Xu, Xin Zhong, et al.
Journal of Inflammation Research|November 11, 2024
GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling PathwayXiaoxi Fan, Wenli Zhang, Ruihan Zheng, et al.
British Journal of Pharmacology|April 1, 2025
GI-Y2, a novel gasdermin D inhibitor, attenuates sepsis-induced myocardial dysfunction by inhibiting gasdermin D-mediated pyroptosis in macrophagesYiling Mei, Xudong Chen, Si Shi, et al.
Experimental and Therapeutic Medicine|September 5, 2014
Regulatory effect of microRNA-135a on the Th1/Th2 imbalance in a murine model of allergic rhinitisYanyun Luo, Yuqin Deng, Zezhang Tao, et al.
Nature Cardiovascular Research|August 28, 2024
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytesJibo Han, Zimin Fang, Bingjiang Han, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Theranostics|February 3, 2025
Deubiquitinase MYSM1 drives myocardial ischemia/reperfusion injury by stabilizing STAT1 in cardiomyocytesXiaowen Shi, Jianjiang Xu, Lei Liu, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2025
MYSM1 Mediates Cardiac Parthanatos and Hypertrophy by Deubiquitinating PARP1Xin Zhong, Jianjiang Xu, Xiaowen Shi, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
Schisandrin B attenuates lipopolysaccharide-induced activation of hepatic stellate cells through Nrf-2-activating anti-oxidative activityZhongcai Yao, Jibo Han, Shuyi Lou, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac RemodelingJibo Han, Shiju Ye, Chunpeng Zou, et al.
Basic Research in Cardiology|December 26, 2016
MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathwayJibo Han, Chunpeng Zou, Liqin Mei, et al.
Cell Communication and Signaling : CCS|December 19, 2024
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytesXiaowen Shi, Jianjiang Xu, Xin Zhong, et al.
Journal of Inflammation Research|November 11, 2024
GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling PathwayXiaoxi Fan, Wenli Zhang, Ruihan Zheng, et al.
British Journal of Pharmacology|April 1, 2025
GI-Y2, a novel gasdermin D inhibitor, attenuates sepsis-induced myocardial dysfunction by inhibiting gasdermin D-mediated pyroptosis in macrophagesYiling Mei, Xudong Chen, Si Shi, et al.
Experimental and Therapeutic Medicine|September 5, 2014
Regulatory effect of microRNA-135a on the Th1/Th2 imbalance in a murine model of allergic rhinitisYanyun Luo, Yuqin Deng, Zezhang Tao, et al.
Nature Cardiovascular Research|August 28, 2024
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytesJibo Han, Zimin Fang, Bingjiang Han, et al.
Pageof 7